reclassify Marinol (dronabinol) from Schedule II to Schedule III
December 1998
The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.
Marinol is a synthetic form of THC...the active ingredient in marijuana. It's used for nausea or to improve appetite in patients with cancer or AIDS.
Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote